Pathogenesis and management strategies of liver failure-associated cholestasis
Liver failure is severe liver injury caused by a variety of factors. Liver failure-associated cholestasis is serious hepatocellular intrahepatic cholestasis with massive hepatocyte necrosis, which manifests as rapid increases in both conjugated and unconjugated bilirubin, and the level of bilirubin...
Main Author: | |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2019-02-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=9586 |
id |
doaj-6fe78899a35842c5927e7596d71a4af2 |
---|---|
record_format |
Article |
spelling |
doaj-6fe78899a35842c5927e7596d71a4af22020-11-25T01:57:57ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562019-02-01352258261Pathogenesis and management strategies of liver failure-associated cholestasisMAO Qing0Department of Infectious Diseases, The First Affiliated Hospital of Army Medical University, Chongqing 400038, ChinaLiver failure is severe liver injury caused by a variety of factors. Liver failure-associated cholestasis is serious hepatocellular intrahepatic cholestasis with massive hepatocyte necrosis, which manifests as rapid increases in both conjugated and unconjugated bilirubin, and the level of bilirubin is directly proportional to the severity of liver failure. Structural changes of liver tissue aggravate intrahepatic cholestasis, and intestinal microbiota can affect bilirubin and bile acid metabolism. The management strategies for liver failure-associated cholestasis include eliminating causes, promoting hepatocyte regeneration, and facilitating liver function recovery.http://www.lcgdbzz.org/qk_content.asp?id=9586 |
collection |
DOAJ |
language |
zho |
format |
Article |
sources |
DOAJ |
author |
MAO Qing |
spellingShingle |
MAO Qing Pathogenesis and management strategies of liver failure-associated cholestasis Linchuang Gandanbing Zazhi |
author_facet |
MAO Qing |
author_sort |
MAO Qing |
title |
Pathogenesis and management strategies of liver failure-associated cholestasis |
title_short |
Pathogenesis and management strategies of liver failure-associated cholestasis |
title_full |
Pathogenesis and management strategies of liver failure-associated cholestasis |
title_fullStr |
Pathogenesis and management strategies of liver failure-associated cholestasis |
title_full_unstemmed |
Pathogenesis and management strategies of liver failure-associated cholestasis |
title_sort |
pathogenesis and management strategies of liver failure-associated cholestasis |
publisher |
Editorial Department of Journal of Clinical Hepatology |
series |
Linchuang Gandanbing Zazhi |
issn |
1001-5256 1001-5256 |
publishDate |
2019-02-01 |
description |
Liver failure is severe liver injury caused by a variety of factors. Liver failure-associated cholestasis is serious hepatocellular intrahepatic cholestasis with massive hepatocyte necrosis, which manifests as rapid increases in both conjugated and unconjugated bilirubin, and the level of bilirubin is directly proportional to the severity of liver failure. Structural changes of liver tissue aggravate intrahepatic cholestasis, and intestinal microbiota can affect bilirubin and bile acid metabolism. The management strategies for liver failure-associated cholestasis include eliminating causes, promoting hepatocyte regeneration, and facilitating liver function recovery. |
url |
http://www.lcgdbzz.org/qk_content.asp?id=9586 |
work_keys_str_mv |
AT maoqing pathogenesisandmanagementstrategiesofliverfailureassociatedcholestasis |
_version_ |
1724971502118371328 |